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Regulation of DNA replication and cell division is
essential for tissue growth and maintenance of
genomic integrity and is particularly important in
tissues that undergo continuous regeneration such
as mammary glands. We have previously shown
that disruption of the KRAB-domain zinc finger pro-
tein Roma/Zfp157 results in hyperproliferation of
mammary epithelial cells (MECs) during pregnancy.
Here, we delineate the mechanism by which Roma
engenders this phenotype. Ablation of Roma in
MECs leads to unscheduled proliferation, replica-
tion stress, DNA damage, and genomic instability.
Furthermore, mouse embryonic fibroblasts (MEFs)
depleted for Roma exhibit downregulation of
p21Cip1 and geminin and have accelerated replication
fork velocities,which is accompaniedbyahigh rateof
mitotic errors and polyploidy. In contrast, overex-
pression of Roma in MECs halts cell-cycle progres-
sion, whereas siRNA-mediated p21Cip1 knockdown
ameliorates, in part, this phenotype. Thus, Roma is
an essential regulator of the cell cycle and is required
to maintain genomic stability.
INTRODUCTION
The adult mammary gland undergoes cycles of proliferation, dif-
ferentiation, and regression with every pregnancy. Mammary
epithelial progenitor cells initially undergo rapid proliferation dur-
ing pregnancy before differentiation into specialized milk-pro-
ducing alveolar cells during lactation. (Watson and Khaled,
2008). We have shown previously that proliferation of alveolar
cells during pregnancy is reduced when the transcription factor
Stat6 is ablated (Khaled et al., 2007). Microarray analysis identi-
fied the Kr€uppel-associated box (KRAB) zinc finger protein,
Zfp157 (herein called Roma—regulator of mammary alveologen-
esis), as the most highly upregulated gene in Stat6/mammary
glands at day 5 gestation (5dG). KRAB-Zfps constitute the
largest family of transcriptional regulators, are found only in tet-724 Cell Reports 15, 724–734, April 26, 2016 ª2016 The Authors
This is an open access article under the CC BY license (http://creativerapods, and are generally transcriptional repressors (Urrutia,
2003). Various functions for these DNA binding proteins are
just beginning to be elucidated (Lupo et al., 2013).
Generation of a Roma-LacZ reporter/functional knockout
(hereafter named Roma/) mouse revealed, as anticipated,
accelerated alveologenesis in pregnant females in concert with
elevated levels of proliferation (Oliver et al., 2012). Unexpectedly,
the ratio of ERa/PR/Gata3-expressing cells to pStat5 cells was
dramatically skewed in favor of the latter when Roma was abla-
ted. Both Stat5 and Gata3 are essential transcription factors for
pregnancy-induced development and ablation of Gata3 from
luminal epithelium during gestation results in lactation failure
arising from death of epithelial cells (Asselin-Labat et al., 2007;
Kouros-Mehr et al., 2006). Surprisingly, this lactation failure
was rescued by coincident loss of Roma. Thus, we concluded
that Roma is a master regulator of the alveolar lineage and that
Gata3 is superfluous when Roma is not expressed (Oliver
et al., 2012). However, the role of Roma in cell-cycle progression
has not been investigated.
The cell cycle is exquisitely regulated by formation of unique
cyclin and cyclin-dependent kinase (CDK) complexes that regu-
late entry into and drive progression of, different phases of the
cell cycle. CDK function is tightly regulated by p21Cip1 and down-
regulation or loss of p21Cip1 is often associated with cell-cycle
dysregulation and aberrant proliferation (Coqueret, 2003).
Furthermore, p21Cip1 is a critical enforcer of the G1 and G2
checkpoints (Shaltiel et al., 2015) and is a component of p53-
mediated responses, and its downregulation compromises the
cellular response to stress. Although much effort has been ex-
pended to determine mechanisms of p21Cip1 regulation, our un-
derstanding of p21Cip1 regulation in the cell cycle is incomplete.
The accurate and precise duplication of DNA occurs during
S phase and to ensure that the genome is duplicated only
once; coordinated licensing and initiation of replication origins
is critical (Blow and Hodgson, 2002). Geminin is a major inhibitor
of replication licensing that prevents excessive firing and un-
scheduled re-firing of origins (Klotz-Noack et al., 2012). Further-
more, modulation of replication fork velocity is important to
circumvent failure to duplicate genomic regions harboring natu-
ral barriers, and p21Cip1 has been implicated in assisting replica-
tion at such regions (Hosfield et al., 1998). Other factors that
regulate fork progression include the Cdc45-GINS-Mcm2–7commons.org/licenses/by/4.0/).
Figure 1. Absence of Roma Leads to Uncon-
trolled Proliferation
(A) Immunofluorescence analysis of EdU incorpo-
ration in mammary gland tissue sections from WT
and Roma/mice at 5dG and 10dL, 24 hr following
injection in vivo. Scale bars, 10 mm. The number of
EdU+ and EdU– cells was counted and presented as
an average percentage. Data are presented as the
mean, and error bars represent SD (5dG: p =
9.52E04, 10dL: p = 2.49E05, Student’s t test).
(B) Protein extracts were prepared from WT and
Roma/ glands at 10dL followed by immunoblot
analysis of cell-cycle factors as indicated. Protein
extract from 5dG WT gland was used as a prolifer-
ation control.
(C) PCR and quantitative real-time PCR analysis of
geminin in extracts from 10dL WT and Roma/
glands (p = 0.0002, Student’s t test).
(D) Immunofluorescence analysis of E-cadherin
staining (green) with binucleate cells indicated
(white arrows). Nuclei are stained with DAPI (blue).
Scale bars, 10 mm.
(E) Immunoblot analysis of cell-cycle factors in ex-
tracts of WT and Roma/ glands at 10dL. Protein
extract from 5dG WT gland was used as a prolifer-
ation control.
(F) Primary MECs were isolated from WT and
Roma/ glands at full wean, and metaphase
spreads were prepared. Karyotype analysis was
carried out, and tetraploidy was determined by
counting the number of chromosomes.
See also Figure S1.(CMG) helicase and DNA topoisomerases. These unwind DNA,
resolve topological tension, andmaintain DNA polymerase proc-
essivity in concert with proliferating cell nuclear antigen (PCNA).
Dysregulation of these events results in re-replication, replication
stress, aneuploidy, and genomic instability, significant events in
tumorigenesis and tumor heterogeneity (Burrell et al., 2013).
Here, we show that Roma is a critical component of themamma-
lian cell cycle that controls replication dynamics and cell-cycle
progression.
RESULTS
Ablation of Roma Leads to Uncontrolled Proliferation
and Prevents Developmentally Programmed
Cell-Cycle Exit
We have previously shown that ablation of Roma results in hy-
perproliferation of MECs in early pregnancy. This is not due to
changes in systemic hormones, and, although the rate of ductal
elongation is accelerated in pubertal Roma/mice, there are no
obvious defects in adult glands (data not shown). The increase in
proliferation in Roma/ glands at 5dG was further supported byCan increased proportion of 5-ethynyl-20-
deoxyuridine (EdU) positive mammary
epithelial cells (MECs) (Figures 1A and
S1A). Notably, at 10 days lactation (10dL)
when cells are terminally differentiated
(Faraldo et al., 2002) and non-proliferativein control glands (Figures 1A andS1A), proliferation is still evident
in Roma/ glands, suggesting that Roma is required for the
transition from cell-cycle progression to quiescence. Increased
EdU labeling was evident also in intestine, spleen, and thymus
of young Roma/ mice (Figure S1B).
Immunoblot analysis of 10dL mammary tissue extracts re-
vealed an increase in levels of replication licensing proteins
(Cdc6, Cdt1, and Mcm3) and replisome components (Cdc45
and GINS) (Figures 1B and S1D), while the licensing inhibitor
geminin was strikingly downregulated at protein and RNA levels
(Figures 1B and 1C). This pattern is consistent with failure to
downregulate replication licensing for cell-cycle exit (Blow and
Hodgson, 2002). Furthermore, Roma/ MECs at 10dG were
found to be undergoing aberrant re-replication (data not shown),
a process suppressed by geminin (Melixetian et al., 2004).
Immunofluorescence analysis revealed a significant increase in
cells expressing Ki67 and PCNA in Roma/ 10dL glands (Fig-
ure S1C). Interestingly, we observed more binucleated cells in
Roma/ in comparison to wild-type (WT) glands (Figure 1D),
indicating cytokinesis failure. The relative increase in Cdh1
levels compared to Cdc20 in Roma/ MECs (Figure 1E) couldell Reports 15, 724–734, April 26, 2016 725
contribute to mitotic slippage (Floyd et al., 2008). This possibility
is supported by elevated levels of securin and themitotic kinases
Aurora A and Plk1 (Figure 1E) that could impede sister chromatid
separation (Petronczki et al., 2008). To investigate further, we
performed karyotype analysis on cells from WT and Roma/
glands after a full lactation and natural wean and found that
Roma deficiency correlated with an approximately 4-fold
increase in tetraploidy (Figure 1F). This suggests that the un-
scheduled proliferation during lactation leads to cell-cycle dysre-
gulation, with chromosomal missegregation and instability.
Unscheduled Proliferation in the Absence of Roma
Leads to Replication Stress and Activation of the DNA
Damage Response
Replication stress results in phosphorylation of the ssDNA bind-
ing protein RPA2 on residue T21 by the ATR/Chk1 kinases. We
noted RPA2 (pT21) foci by immunofluorescence analysis of
10dL Roma/ glands (Figure 2A). Furthermore, collapse of
stalled forks to form double-strand breaks (DSBs) is evidenced
by gH2AX foci and presence of large 53BP1 foci (Figure 2A),
reminiscent of 53BP1-OPT domains observed in G1 cells (Harri-
gan et al., 2011) that mark replication stress-mediated DNA le-
sions arising from the previous S phase (Lukas et al., 2011).
Immunoblot analysis revealed activation of ATR-Chk1-driven S
and G2 phase checkpoints and p53 activation as evidenced by
p53 (pS15) levels and upregulation of Gadd45 (Figures 2B and
S2A). Intriguingly, another major downstream target of p53,
p21Cip1, which is an important effector of cell-cycle arrest upon
checkpoint activation, is not correspondingly upregulated in
the absence of Roma (Figure 2B). Indeed, quantitative real-
time PCR analysis indicated that p21Cip1 was transcriptionally
downregulated in Roma/ glands compared to WT (Figure 2C).
RNA levels of other DNA damage responders such as Blm, Fen1,
and Rrm1, which localize to stalled forks are also upregulated
(Figure S2B).
These data indicate that Roma insufficiency results in un-
scheduled proliferation, replication stress, and DNA damage,
which would activate the G2/M checkpoint. A key player is
Wee1, which negatively regulates CDK1 to prevent mitosis
(Lianga et al., 2013), and Wee1 levels are diminished in
Roma/mammary glands (Figure 1E). The increased proportion
of binucleated cells upon Roma loss (Figure 1D) further supports
the notion of defects in G2/M checkpoint arrest and/or check-
point bypass probably arising from the decreased levels of
Wee1 and p21Cip1.
Hence, it is not surprising thatwe observed an increase in gross
structural chromosomal rearrangements in Roma/ glands
compared to WT (Figures 2D and S2C). Such genomic damage
couldarise fromDNA replicationerrorsand/orSphasecheckpoint
defects (Myung et al., 2001). Since key genes such as p21Cip1 and
geminin are transcriptionally dysregulated in the absence of
Roma, these effects could be mediated initially at the transcrip-
tional level via recruitment of Roma and additional co-factors,
such as KAP-1, to the promoters of a subset of these genes.
Roma Regulates Replication Fork Dynamics
These data highlight a role for Roma in cell-cycle regulation. To
facilitate mechanistic analysis, we derived primary mouse em-726 Cell Reports 15, 724–734, April 26, 2016bryonic fibroblasts (MEFs) from WT and Roma/ mid-gestation
embryos. Immunoblot analysis of a panel of cell-cycle regulators
recapitulated the observations in 10dL mammary glands
(Figure S3A), providing us with a tractable in vitro system. We
investigated replication dynamics by pulse-labeling MEFs with
iododeoxyuridine (IdU) followed by chlorodeoxyuridine (CldU)
after which DNA fibers were spread and analyzed (Figure 3A).
Surprisingly,Roma/MEFs exhibited an approximately 45% in-
crease in overall replication fork velocity compared to WT (1.6 ±
0.4 and 1.1 ± 0.02 kb/min, respectively) (Figures 3A and S3B).
Furthermore, in Roma/ MEFs, inter-origin distances were
larger than in WT (130 ± 7 and 105 ± 4 kb, respectively) (Fig-
ure 3B). Roma/ MEFs are characterized by, on average, one
less replication origin per megabase than WT MEFs (4.6/Mb
and 6.1/Mb, respectively) (Table S1), which could be a conse-
quence of the faster moving forks in Roma/ cells inactivating
adjacent replication origins (Blow and Ge, 2008).
The increased replication fork speeds could result from failure
to pause at DNA secondary structures and repetitive DNA se-
quences (Mazouzi et al., 2014) and could lead, potentially, to
under-replicated areas, replication stress, and DNA damage
response activation. Supporting this possibility, immunoblot
analysis showed ATR/Chk1 and p53 activation (Figure 3C).
These profiles are remarkably similar to those observed in mam-
mary gland suggesting that aberrant DNA replication occurs also
in the absence of Roma in vivo. Again, levels of p21Cip1 were not
correspondingly upregulated to reinforce the G2/M checkpoint.
2D cell-cycle analysis of WT and Roma/ MEFs by pulse la-
beling with bromodeoxyuridine (BrdU) to identify cells in S phase
revealed striking aneuploidy and polyploidy in Roma/ MEFs
after only five passages (Figures 3D and S3C). Measurement of
the proportion of cells in either S phase (high BrdU content) or
in G1/G2/M (low BrdU content) demonstrated that strikingly
fewer Roma/ MEFs are in S phase (7%) compared to WT
(35%). Roma/ MEFs also incorporated BrdU at a higher rate,
consistent with them progressing faster through S phase.
During live-cell imaging of Roma/ MEFs, we noted that,
while they are able to form themitotic cleavage furrow character-
istic of telophase, they subsequently fail to divide (Movies S1 and
S2). This impairment of cytokinesis in vitro correlates with
elevated levels of Plk1, Aurora A, and securin (Figure 3E), that
would impede sister chromatid separation. SAC components
such as BubR1 are elevated in Roma/ MEFs (Figure 3E) as
are levels of Mps1, which contributes to inhibition of proper
mitotic exit in the presence of misaligned chromosomes (Althoff
et al., 2012). Taken together, these observations suggest aber-
rant mitotic bypass and ploidy.
One possible interpretation of the increased fork velocities
observed in Roma/ MEFs is that, in the absence of Roma,
downregulation of p21Cip1 stabilizes interactions between
PCNA and DNA polymerase d (Sexton et al., 1997). p21Cip1 has
a role also in facilitating fork pausing at natural barriers through
interactions with PCNA and Fen1 (Hosfield et al., 1998). Immuno-
precipitation experiments in EpH4 normal MECs expressing a
doxycycline-inducible Roma FLAG-tagged construct (Figure 3F)
suggest that Roma interacts with Mcm2, Mcm3, and DNA Topo-
isomerase I although the binding domains required for these in-
teractions have yet to be determined (Figure S3D). We propose
Figure 2. Absence of Roma Leads to Activation of the DNA Damage Response and Genomic Instability
(A) Representative immunofluorescence analysis of RPA2-pT21, gH2AX, and 53BP1 foci in tissue sections fromWT andRoma/ glands at 10dL. Thewhite arrow
indicates nucleolar gH2AX. Scale bars, 10 mm. The higher magnification panels on the right have been chosen to highlight the foci and are not zoomed images of
the left panels.
(legend continued on next page)
Cell Reports 15, 724–734, April 26, 2016 727
that loss of association between Roma and these key replication
factors in Roma/ MEFs could potentially influence their re-
cruitment and function at replication forks, contributing to an
increase in replication fork speeds. This could lead to under-
replication of some regions of the genome with coincident
DNA damage that would activate the G2/M checkpoint enforced
by p21Cip1. However, given the downregulation of p21Cip1 when
Roma is ablated (Figures 3C and 3E), we posit that cells are able
to bypass the checkpoint and enter mitosis. Furthermore, it has
been shown that p21Cip1 is critical in preventing S phase entry
after aberrant mitotic exit through cyclin E-CDK2 inhibition
(Stewart et al., 1999). Hence, the downregulation of p21Cip1
would explain both the polyploidy and the continued cell-cycle
progression in cells lacking Roma.
Another possible interpretation of the above data is that
Roma/ cells are undergoing endoreduplication without appro-
priate cell division. The re-replication or endoreduplication of
cells arrested in G2 is strongly enhanced by the loss of p21Cip1
(Khan and Wahl, 1998) or geminin (Klotz-Noack et al., 2012).
Overexpression of Roma Leads to Cell-Cycle Collapse
Next, we sought to investigate the impact of Roma overexpres-
sion in EpH4 normal MECs using a doxycycline-inducible
Roma FLAG-tagged construct (Figures S4A and S4C). Roma
overexpression inhibited proliferation as evidenced by a de-
crease in total cell numbers over a 6-day time course (Figure 4A).
Cell morphology was altered, with cells switching from a
cuboidal epithelial form to a more elongated, spindle-shaped
phenotype after prolonged induction of Roma expression (Fig-
ure 4B). Immunofluorescence analysis with an anti-FLAG anti-
body revealed an aggregation of Roma-FLAG into distinct foci
after 24 hr doxycycline induction (Figure S4D). These foci are
reminiscent of replication foci (Toledo et al., 2013), supporting
the involvement of Roma at the replication fork level.
BrdU analysis of EpH4 cells overexpressing Roma revealed
that high levels of Roma led to S phase collapse with a lack of
DNA synthesis (Figure 4C, top panel). It is striking that high levels
of Roma do not lead to arrest at a specific cell-cycle phase but
rather, cells are halted in G1, S, and G2/M. The sub-G1 popula-
tion also suggests that Romamay induce cell death. Immunoblot
analysis revealed a rapid increase in p21Cip1 levels within 6 hr
that was independent of p53 activation (Figures 4D and S4E).
Transcriptional upregulation of p21Cip1 occurred within 4 hr of
Roma expression being induced (Figure 4E, top panel). p21Cip1
can block origin firing by inhibiting CDK activity and binding
PCNA, precluding its interaction with DNA polymerase d (Waga
et al., 1994). p21Cip1 inhibition of G2, M, and G1 CDKs would
further contribute to the full cell-cycle arrest observed. Another
factor that was rapidly upregulated in response to Roma overex-
pression was geminin. Protein levels are increased after 8-hr(B) Immunoblot analysis of cell-cycle checkpoint and DNA damage response in ex
with 5mM HU were used as a damage control.
(C) PCR analysis of p21Cip1 and MDM2 and quantitative real-time PCR analysis o
t test).
(D) Representative spectral karyotypes (top) and metaphase spreads (bottom p
natural wean.
See also Figure S2.
728 Cell Reports 15, 724–734, April 26, 2016induction (Figure 4D), while an increase in RNA was evident by
6 hr (Figure 4E, top panel). Increased geminin would arrest cells
in late mitosis and G1 through Cdt1 inhibition and promotion of
Cdt1 degradation by the E3 ubiquitin ligases SCFSkp2 and
Cul4-Ddb1Cdt2, leading to the rapid decrease in Cdt1 levels
observed (Figure S4E).
Upon release from doxycycline, Roma levels decline rapidly,
possibly by ubiquitin-mediated degradation (Figure S4F), and
cells previously arrested in S phase appear to resume replication
within 2 hr of release (Figure 4C, bottom panel). p21Cip1 RNA and
protein levels start to decrease by 4 and 6 hr, respectively (Fig-
ure 4E, bottom panel; Figure S4G), independent of p53. Notably,
arrested cells that re-enter the cell cycle appear to undergo en-
doreduplication after 6 hr (Figure 4C, bottom panel). Cells
released from p21Cip1-induced G2 arrest undergo endoredupli-
cation as p21Cip1 interferes with checkpoints that prevent re-en-
try into S phase without prior mitosis (Niculescu et al., 1998). The
cell death observed after 8 hr is likely the fate of endoreduplicat-
ing cells upon G1 checkpoint activation (Figure 4C, bottom
panel).
Together, these results suggest that Roma overexpression
rapidly, and reversibly, leads to S phase collapse and cell-cycle
arrest. Given that p21Cip1 is transcriptionally upregulated when
Roma is overexpressed, we knocked down p21Cip1 (Figure S4H)
and observed that this alleviated the cell-cycle arrest induced by
Roma overexpression, suggesting that excess Roma can
mediate S phase arrest primarily through upregulation of
p21Cip1 (Figure 4F). However, since p21Cip1 knockdown did not
completely prevent cell-cycle arrest but rather led to an accumu-
lation of cells in G1, we suggest that geminin, which is also tran-
scriptionally regulated by Roma (data not shown) could be
responsible for blocking S phase entry by inhibiting replication
licensing (Figures 4D and 4E). Clearly, levels of Roma need to
be exquisitely regulated in order to maintain cell-cycle progres-
sion with excess, or insufficient, Roma resulting in cell-cycle
arrest or unscheduled DNA replication and genomic instability.
DISCUSSION
KRAB-domain zinc finger proteins (KRAB-Zfps) comprise a large
family of rapidly evolving DNA binding proteins that are unique to
tetrapods and impart tissue specific functions (Urrutia, 2003).
Roma is a KRAB-Zfp with a previously unsuspected role as a
regulator of mammalian cell-cycle progression through modula-
tion of multiple cell-cycle components and control of replication
fork velocity. We have identified p21Cip1 and geminin as
critical downstream targets of Roma and demonstrated phy-
sical interaction between Roma and components of the repli-
cation machinery such as Mcm2/3 and DNA Topoisomerase I.
Loss of Roma results in increased replication fork speeds andtracts fromWT and Roma/ glands at 10dL. Extracts from U2OS cells treated
f p21Cip1 in extracts from 10dL WT and Roma/ glands (p = 0.0007, Student’s
anel) prepared from MECs isolated from WT and Roma/ glands after a full
(legend on next page)
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checkpoint bypass resulting in polyploidy and genomic insta-
bility. This could predispose to tumorigenesis, and our previous
study showed that Roma deficiency results in hyperplasia in
mammary alveolar cells that have been depleted also of Gata3
(Oliver et al., 2012).
We show that the quiescence associated with differentiated
MECs during lactation is dependent on appropriate levels of
Roma. p21Cip1 has long been implicated in terminal differ-
entiation of multiple cell types: skeletal muscle myogenesis is
associated with p21Cip1 upregulation (Guo et al., 1995), and
p21Cip1-deficient keratinocytes exhibit reduced differentiation
(Missero et al., 1996). Absence of p21Cip1 has been implicated
in enhancing appendage regeneration in mice through unsched-
uled S phase entry (Bedelbaeva et al., 2010). Likewise, in mam-
mary gland development, Roma regulation of p21Cip1 might be
important in inducing quiescence in secretory epithelial cells dur-
ing lactation. Furthermore, Roma is expressed at higher levels in
basal epithelial cells, which cycle less frequently than luminal
cells (Zeps et al., 1999).
Apart from preventing re-licensing and re-replication, geminin
prevents over-cycling and exhaustion of multipotent progenitor
populations and promotes genomic stability in long-term repo-
pulating hematopoietic stem cells by inducing quiescence (Taki-
hara, 2011). The transcriptional downregulation of geminin in the
absence of Roma might be another contributing factor in the
failure ofRoma/MECs in lactating glands to enter G0. Interest-
ingly, in human breast tissue, there is a lack of correlation be-
tweenMcm2–7 levels andmarkers of proliferation with one study
showing that more than 50% of breast epithelial cells expressed
Mcm2–7, although only 6% were proliferative (Stoeber et al.,
2001). Thus, unlike other tissues, most breast epithelial cells
are licensed but not actively cycling. This could render the mam-
mary gland particularly sensitive to changes in the relative levels
of cell-cycle regulators such as geminin and p21Cip1. Hence,
appropriate regulation of geminin by Roma could be essential
as a safeguard against mammary tumorigenesis. We suggest
that Roma and Stat6 interact in a negative transcriptional regula-
tory loop whereby Stat6 suppresses Roma expression specif-
ically in luminal cells during pregnancy to allow elevated levels
of proliferation while maintaining sufficient levels of Roma to pre-
vent unscheduled DNA replication. Roma may have an addi-
tional role as an integral component of the replication fork, a
notion that will require further investigation.
Although not described in mammary gland, physiological in-
stances of re-replication and accumulation of polyploid cellsFigure 3. Altered Replication Dynamics and Aneuploidy in Roma-Defic
(A) Primary MEFs were isolated fromWT and Roma/ embryos and cultured in vi
and CldU and counterstained with anti-DNA antibodies to ensure that broken fibe
presented as mean ± SD.
(B) Interorigin distances in WT and Roma/ MEFs were measured. Data are pre
(C) Protein extracts were prepared from WT and Roma/ primary MEFs followe
damage response. Extract from U2OS cells treated with 5 mM HU was used as
(D) PrimaryWT andRoma/MEFswere pulsed with BrdU, and cell-cycle analysis
(E) Immunoblot analysis of cell-cycle factors. Protein extract from 5dG WT gland
(F) EpH4 cells were transfected with a Roma-FLAG expression construct and cult
expression. Protein extracts were prepared from EpH4 cells under the stated con
Mcm3, and DNA Topoisomerase I showing association with Roma-FLAG.
See also Figure S3.
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yocytes, which have DNA contents between 8N to 64N. This re-
sults from endoreduplication in TG cells and endomitosis in
megakaryocytes and has been associated with inhibition of
CDK1 activity by p57, and suppression of DNA damage signaling
by p21Cip1 (Ullah et al., 2008). However, under non-physiological
conditions, inactivation of p21Cip1 can enhance endoreduplica-
tion, albeit leading to apoptosis (Jiang et al., 2000). The switch
from mitotic cycles to endocycles has been linked to the degra-
dation and loss of factors critical for mitotic entry such as cyclin
B1, Plk1, and Aurora B by APCCdh1 (Edgar et al., 2014). However,
given the upregulation of these factors in the absence of Roma,
the accumulation of polyploid cells is likely to be a consequence
of checkpoint escape and cell division failure.
We suggest, therefore, that Roma has a critical role in deter-
mining whether a cell can progress unperturbed through the
cell division cycle and is required at precise stoichiometric levels
in late G1/S phase to control replication fork progression. Roma
appears also to be required in G2/M phase to ensure completion
of cell division and genomic stability. The observation of hyper-
proliferation in gut, thymus, and spleen of Roma/mice implies
a wider role for this transcriptional regulator. The identification of
a critical role for Roma in controlling proliferation and genomic
stability suggests that Romamay be a tumor suppressor, partic-
ularly in the breast, and awaits further studies.
EXPERIMENTAL PROCEDURES
Animals
Roma knockout mice were generated as described (Oliver et al., 2012). 7- to
8-week old virgin female mice were mated and plug-checked to confirm preg-
nancy. All animals were treated according to the local ethical committee
(AWERB) and the UK Home Office guidelines.
Tissue Sections and Immunofluorescence
Tissues were collected from abdominal glands and fixed in 4% paraformalde-
hyde overnight and stored in 70%ethanol. Tissueswere embedded inwax and
sectioned at 4-mm thickness. Sections were deparaffinized, and antigen was
retrieved and stained as described in Oliver et al. (2012). Antibodies used
were E-cadherin (BD Pharmingen, #610182), RPA32/RPA2 (pT21; Abcam,
ab109394), H2AX (pS139; Millipore, 05-636), 53BP1 (Novus Biologicals,
NB100-304), and DYKDDDDK Tag (Cell Signaling Technology, #2368). Slides
were visualized with a Zeiss confocal microscope.
PCR
RNA extraction of mammary tissue was carried out as described (Oliver et al.,
2012). RT-PCR was performed using 2 ml of cDNA, and samples were cycledient Cells
tro. DNA fibers from these cells were spread and stained with antibodies to IdU
rs were not analyzed. Replication fork velocities were then measured. Data are
sented as mean ± SD.
d by immunoblot analysis of markers of cell-cycle checkpoints and the DNA
a damage control.
was conducted. Percentage of cells in G1/G2/M and S phaseswas calculated.
was used as a proliferation control.
ured under puromycin selection. Doxycycline was used to induce Roma-FLAG
ditions followed by FLAG immunoprecipitation and immunoblot against Mcm2,
Figure 4. Overexpression of Roma Results in S Phase Arrest
(A) EpH4 cells were transfected with a Roma-FLAG expression construct and cultured under puromycin selection. Doxycycline was used to induce Roma-FLAG
expression. Cell counts were monitored over the course of a week and represented in a graph.
(B) Representative images of cells under the indicated conditions.
(legend continued on next page)
Cell Reports 15, 724–734, April 26, 2016 731
27 times. Parameters were 95C 5 min; 95C 30 s, 60C 30 s, 72C 30 s; 72C
7 min; 4C hold. Primers used were p21Cip1 forward (GCAGATCCACAGCGA
TATC); reverse (CAACTGCTCACTGTCCACG); Geminin forward (GGAGC
ATTGCTGTCTCTGAA); reverse (TCTTCAGCGTTCTCCTTGGG).
Immunoblotting
Western blotting was performed as described (Oliver et al., 2012). Antibodies
used were Cyclin D1 (Cell Signaling Technology, #2978), PCNA (Santa Cruz
Biotechnology, sc-56), Geminin (Santa Cruz Biotechnology, FL-209), RPA32/
RPA2 (pT21) (Abcam, ab109394), H2AX (pS139) (Millipore, 05-636), p53 (Santa
Cruz Biotechnology, sc-126), p21 (BD Pharmingen, #556430), MDM2 (BD
Pharmingen, #556353), DYKDDDDK Tag (Cell Signal, #2368), E2F1 (Bethyl,
A300-766A), p53 (pS15) (Cell Signal, #9284), MDC1 (Bethyl, A300-053A),
Cyclin E (Cell Signal, #4129), ATR (pS428) (Cell Signal, #2853), CHK1
(pS345) (Cell Signal, #2341), RAD51 (Abcam, ab63801), Cyclin B1 (Abcam,
ab52187), Cdc6 (Santa Cruz Biotechnology, sc-8341), ORC3 (Santa Cruz
Biotechnology, sc-23888), DNA pola (Santa Cruz Biotechnology, sc-
365039), Cdk2 (Santa Cruz Biotechnology, sc-163), Cdk1 (Abcam, ab18),
Wee1 (Abcam, ab137377), Rb (Santa Cruz Biotechnology, sc-50), Cdh1
(Abcam, ab154539), Cdc20 (Cell Signal, #4823), Securin (Abcam, ab3305),
GINS (Santa Cruz Biotechnology, sc-373595), Cdc45 (Santa Cruz Biotech-
nology, sc-20685), Aurora A (Cell Signal, #3092), Plk1 (Abcam, ab17056),
Gadd45 (Cell Signal, #4632), Emi1 (Santa Cruz Biotechnology, sc-30182),
BubR1 (Santa Cruz Biotechnology, sc-16195), ATM (BD Pharmingen,
560007), ATM (pS1981) (Cell Signal, #4526), CHK2 (pT68) (Cell Signal, #16297),
Cdt1 (Stavros Taraviras), and MCM3 (Nick Coleman).
Primary Mammary Cell and Metaphase Preparation
Cells were isolated from mammary glands after a full natural wean according
to Stingl et al. (2006) and cultured in complete media consisting of 10% fetal
calf serum (FCS) in DMEM, gentamicin, 5 mg/ml insulin, and 10 ng/ml murine
epidermal growth factor. Cells were treated with 0.1 mg/ml of nocodazole
(Sigma-Aldrich). Cells were pelleted and 7ml of pre-warmed 0.05M KCl
was added with gentle swirling followed by incubation for 12 min at 37C.
10 ml of 3:1 methanol:acetic acid fixative was added dropwise before pellet-
ing cells. R e-suspension in 5ml 3:1 methanol:acetic acid fixative was
repeated thrice before cells were re- suspended in 2ml of 3:2 methanol:ace-
tic acid fixative.
Primary MEF Preparation
13.5-day-old embryos were harvested. Viscera were dissected away and car-
casses were cut into small fragments. 3 ml trypsin/EDTA was added and incu-
bated for 5 min at 37C. Plates were rinsed with 5 ml 10% FCS in DMEM with
gentamicin. Cells were re-suspended in 2 ml trypsin/EDTA and incubated for
5 min at 37C. 8ml of media was added and mixed by inversion before plating.
In Vivo EdU Injections
500 mg of EdU (5-ethynyl-20-deoxyuridine; Life Technologies) was adminis-
tered at the various time points stated via intra-peritoneal injection 24 hr prior
to tissue collection. Tissues were fixed in 4% paraformaldehyde for 2 hr at
room temperature before transferring to 70% ethanol. Detection of EdU was
done with the Click-iT EdU imaging kit (Invitrogen) as per manufacturer’s
instructions.
Overexpression of Roma-FLAG in EpH4 Cells
Roma-FLAG was cloned into a PiggyBac transposon system, and EpH4 cells
were transfected via the Amaxa nucleofector protocol (Lonza) as per manufac-
turer’s instructions.(C) EpH4 cells transfected with a Roma-FLAG expression construct were treated
and pulsed with BrdU followed by flow cytometry analysis.
(D) Protein extracts were prepared from EpH4 cells at conditions stated and imm
was conducted.
(E) RNA was extracted from EpH4 cells cultured in conditions stated followed by
(F) EpH4 cells cultured in conditions stated were treated with p21Cip1 siRNA an
See also Figure S4.
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Cells were harvested by scraping in cold PBS and re-suspended in RIPA
lysis buffer with protease inhibitor cocktail. 2 mg of protein was used per
immunoprecipitation. Anti-FLAG M2 affinity gel (Sigma-Aldrich, A2220)
was prepared as per manufacturer’s instructions and incubated with pro-
tein lysate overnight at 4C with rotation. For immunoprecipitation with
anti-Mcm2 (BD Transduction, 610700) and anti-DNA-TopI (Abcam,
ab3825), Protein G sepharose 4 Fast Flow (GE Healthcare, GE17-0618-
02) was used.
Small Interfering RNA
ON-TARGETplus SMARTpool small interfering RNA (siRNA) against p21/
Cdkn1a (Dharmacon, L-058636-00-0005) and ON-TARGETplus Non-targeting
pool siRNA (Dharmacon, D-001810-10-05) as negative control were used.
Cell-Cycle Analysis with BrdU
Cell-cycle analysis was done as described (Frey et al., 2014) with the
minor modification that MEFs were trypsinized after the 30-min BrdU
incorporation.
Preparation, Spreading, and Immunolabeling of DNA Fibers
DNA fiber spreading was done as described (Frey et al., 2014) with minor
modifications as follows: MEFs were incubated with 25 mM IdU for 15 min
and supplied with fresh medium containing 25 mM CldU for another 15 min.
Cells were trypsinized with 103 trypsin. Immunostaining and analysis were
carried out as described (Guilbaud et al., 2011).
Statistical Analysis
Statistical significance was assessed using unpaired two-tailed Student’s
t tests in Microsoft Excel (TTEST).
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Supplemental Figure Legends  
Figure S1 (Related to Figure 1) (A) Average percentages of EdU+ cells per alveolar structure in WT and Roma
-/-
 
mammary glands at 5dG and 10dL (n=3 mice per group, 5dG: p = 9.52E-04, 10dL: p = 2.49E-05, Student’s t-test). (B) 
In vivo IP injections of EdU in WT and Roma
-/-
 mice at 7-8 weeks of age and various organs harvested. Number of 
EdU+ cells per field of view were counted at 20X magnification for small intestine and 40X magnification for spleen 
and thymus and presented as an average percentage of positive cells to total cells counted. (n=3 mice per group, Small 
intestine: p = 1.84E-06, Spleen: p = 1.19E-05, Thymus: p = 1.65E-07, Student’s t-test). (C) Immunofluorescence 
analysis of WT, Roma
+/-
 and Roma
-/-
 mammary glands at 10dL with Ki67 and PCNA. Average percentages of Ki67+ or 
PCNA+ cells per field of view at 20X magnification were calculated. Data is presented as mean and error bars represent 
standard deviation (SD). (n=3 mice per group, Ki67: WT vs Roma
+/-
: p = 0.024; WT vs Roma
-/-
: p = 0.008; PCNA: WT 
vs Roma
+/-
: p = 0.001; WT vs Roma
-/-
: p = 4.73E-06; Student’s t-test). (D) Protein extracts were prepared from WT and 
Roma
-/-
 mammary glands at 10dL (n=3 mice per group) followed by immunoblot analysis of cell cycle factors. Extract 
from 5dG WT gland used as proliferation control.  
Figure S2 (Related to Figure 2) (A) Immunoblot analysis of cell cycle checkpoints and DNA damage response 
markers in WT and Roma
-/-
 mammary glands at 10dL (n=3 mice per group). Extract from U2OS cells treated with 5 
mM HU was used as a damage control. (B) PCR analysis of various cell cycle checkpoints and DNA damage response 
markers in WT and Roma
-/-
 mammary glands at 10dL (n=3 mice per group) were conducted. Cyclophilin used as an 
internal control. (C) Summary of gross chromosomal rearrangements in WT and Roma
-/-
 mammary epithelial cells 
isolated from mammary glands after a full natural wean (n=3 mice per group).  
Figure S3 (Related to Figure 3) (A) Immunoblot analysis of cell cycle factors in WT and Roma
-/-
 MEFs (n=3 clones 
per group). Extract from 5dG WT gland was used as a proliferation control. (B) A selection of representative fibers 
analysed. (C) Primary WT and Roma
-/-
 MEFs at passage 5 were pulsed with BrdU followed by cell cycle analysis using 
flow cytometry (n=3 clones per group). (D) Protein extracts were prepared from EpH4 cells under the following 
conditions: untransfected EpH4 cells+48h doxycycline, EpH4+control FLAG vector (Puromycin selection), 
EpH4+Roma-FLAG vector (Puromycin selection, no induction), EpH4+Roma-FLAG vector + 48h doxycycline 
(Puromycin selection, induction), EpH4+Roma-FLAG vector+48h doxycycline+benzonase treatment (Puromycin 
selection, induction) followed by Mcm2 and DNA Topoisomerase I immunoprecipitation respectively and immunoblot 
against Roma-FLAG showing association.  
Figure S4 (Related to Figure 4) (A) Protein extracts were prepared from EpH4 cells under puromycin selection 
(without doxycycline induction) and at various timepoints after doxycycline-induced Roma-FLAG expression. FLAG 
immunoprecipitation was conducted followed by immunoblot analysis of Roma-FLAG expression. (B) RNA was 
extracted from EpH4 cells under puromycin selection (without doxycycline induction) and at various timepoints after 
doxycycline-induced Roma-FLAG expression and PCR analysis of p21
Cip1
 and geminin was conducted. Cyclophilin 
used as an internal control. (C) Untransfected EpH4 cells were treated with doxycyline for 48h before pulsing with 
BrdU followed by cell cycle analysis. (D) Representative immunofluorescence analysis of PCNA and Roma-FLAG in 
EpH4 cells at various timepoints after doxycycline-induced Roma-FLAG expression. Scale bars = 10μm. (E) 
Immunoblot analysis of cell cycle factors in EpH4 cells during a timecourse of doxycycline-induced Roma-FLAG 
expression was conducted. (F) Protein was extracted from EpH4 cells over a timecourse of release from doxycycline-
induced Roma-FLAG expression (+/- MG132) followed by anti-FLAG immunoblot analysis. Protein extracts were 
prepared from EpH4 cells under the stated conditions followed by FLAG immunoprecipitation and immunoblot against 
KAP1 showing association with Roma-FLAG. (G) Immunoblot analysis of cycle checkpoint, DNA damage response 
and cell cycle factors in EpH4 cells during a timecourse of release from doxycycline-induced Roma-FLAG expression 
was conducted. (H) Protein was extracted from EpH4 cells under the following treatment conditions – untreated, 
scrambled siRNA, 25nM p21
Cip1
 siRNA, 50nM p21
Cip1
 siRNA followed by immunoblot for p21
Cip1
. Extract from 5dG 
WT gland was used as a proliferation control. Protein was extracted from EpH4 cells under the stated treatment 
conditions (+/- 50nM p21
Cip1
 siRNA) followed by immunoblot against p21
Cip1
.  
Video S1 (Related to Figure 3) 
Video clip of WT MEFs during live cell imaging. 
Video S2 (Related to Figure 3) 
Video clip of Roma
-/-
 MEFs during live cell imaging.  
Table S1 (Related to Figure 3) 
A separate Excel Workbook containing raw data from DNA fiber analysis.  
 
Supplemental Experimental Procedures 
Quantification of EdU-positive cells in other tissues 
For intestine, images were taken at 20X magnification and 10 fields of view were counted. For spleen and thymus, 
images were taken at 40X magnification and 5 fields of view were counted. Analysis was conducted as stated in 
Experimental Procedures.  
Quantification of PCNA and Ki67-positive MECs 
For the analysis of PCNA+ and Ki67+ cells, images were taken at 20X magnification and 10 fields of view were 
analyzed per gland. Number of PCNA+ or Ki67+ cells were expressed as a percentage of total number of cells. 
Statistical significance was assessed using unpaired two-tailed Student's t-tests in Microsoft Excel (TTEST).  
PCR 
Other primers used include (PCR parameters can be found under Experimental Procedures): 
Cyclin B1 – forward (CAGAGTTCTGAACTTCAGCCTG); reverse (TTGTGAGGCCACAGTTCACCAT) 
CDK1 – forward (ACAGAGAGGGTCCGTCGTAA); reverse (ATTGCAGTACTGGGCACTCC) 
MDM2 – forward (TTAGTGGCTGTAAGTCAGCAAGA); reverse (CCTTCAGATCACTCCCACCT) 
RPA2 – forward (TGTTGGCGGCAGAATCATGG; reverse (CTCGTCAAGTGGCTCCATCAA) 
BLM – forward (AAGCCTGAGTGAGGATCATGG); reverse (TGACAGACACATCACCCTCTG) 
FEN1 – forward (GCTAGCTGCTTAAGGCTCGT); reverse (AGGAGCAATGGCTTCTTCCTAC) 
RAD54 – forward (TGGACCCAAGCCTCATCCTC) 
reverse (TAAGCTCCTCCTCATCCTGGC) 
RRM1 – forward (ACGAAGCACCCTGACTATGC); reverse (TGGCAGAATTCAGGCGATCC) 
Clspn – forward (GCACTGCAGAAGAATGCCAG); reverse (TTCCTTGAGTTTCGGGGAGC) 
Mgst – forward (AAGATTGGAAGCATGGCCGA); reverse (CTGGGTTGGCAAAAACCTTGT) 
 
